Imperia Fenugreek
Natural health product licensed in Canada
- Licence holder
- Imperia Brand Strategies & Solutions Ltd.
- NPN or DIN-HM
- 80045702
- Status
- Active licence
- Licence date
- 23 October 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Phosphate dicalcique, Croscarmellose de sodium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 4 Comprimé | 1 day |
Uses authorised in Canada
(Traditionally) used in Herbal Medicine as a digestive tonic to aid digestion. (Traditionally) used in Herbal Medicine as a galactogogue/lactogogue to help promote milk production/secretion. (Traditionally) used in Herbal Medicine as a nutritive tonic. (Traditionally) used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. (Traditionally) used in Herbal Medicine to help relieve dyspepsia and gastritis. (Traditionally) used in Herbal Medicine to help stimulate the appetite. Traditionally used in Herbal Medicine as an expectorant to help relieve excess mucous of the upper respiratory passages (anti-catarrhal). Used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidemia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are pregnant. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner if symptoms persist.
Source
Official Health Canada record, licence 80045702
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.